Literature DB >> 16131654

Mycobacterium tuberculosis Rv2536 protein implicated in specific binding to human cell lines.

Javier García1, Alvaro Puentes, Luis Rodríguez, Marisol Ocampo, Hernando Curtidor, Ricardo Vera, Ramses Lopez, John Valbuena, Jimena Cortes, Magnolia Vanegas, Carlos Barrero, Manuel A Patarroyo, Mauricio Urquiza, Manuel E Patarroyo.   

Abstract

The gene encoding the Mycobacterium tuberculosis Rv2536 protein is present in the Mycobacterium tuberculosis complex (as assayed by PCR) and transcribed (as determined by RT-PCR) in M. tuberculosis H37Rv, M. tuberculosis H37Ra, M. bovis BCG, and M. africanum strains. Rabbits immunized with synthetic polymer peptides from this protein produced antibodies specifically recognizing a 25-kDa band in mycobacterial sonicate. U937 and A549 cells were used in binding assays involving 20-amino-acid-long synthetic peptides covering the whole Rv2536 protein sequence. Peptide 11207 (161DVFSAVRADDSPTGEMQVAQY180) presented high specific binding to both types of cells; the binding was saturable and presented nanomolar affinity constants. Cross-linking assays revealed that this peptide specifically binds to 50 kDa U937 cell membrane and 45 kDa A549 cell membrane proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16131654      PMCID: PMC2253470          DOI: 10.1110/ps.051526305

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  28 in total

1.  Identification of specific Hep G2 cell binding regions in Plasmodium falciparum sporozoite-threonine-asparagine-rich protein (STARP).

Authors:  Ramsés López; Javier Garcia; Alvaro Puentes; Hernando Curtidor; Marisol Ocampo; Ricardo Vera; Luis Eduardo Rodriguez; Jorge Suarez; Mauricio Urquiza; Ana Liliana Rodríguez; Claudia Alexandra Reyes; Carmen Giovana Granados; Manuel E Patarroyo
Journal:  Vaccine       Date:  2003-06-02       Impact factor: 3.641

2.  Peptides of the liver stage antigen-1 (LSA-1) of Plasmodium falciparum bind to human hepatocytes.

Authors:  Javier E García; Alvaro Puentes; Ramsés López; Ricardo Vera; Jorge Suárez; Luis Rodríguez; Hernando Curtidor; Marisol Ocampo; Diana Tovar; Martha Forero; Adriana Bermudez; Jimena Cortés; Mauricio Urquiza; Manuel E Patarroyo
Journal:  Peptides       Date:  2003-05       Impact factor: 3.750

3.  Sporozoite and liver stage antigen Plasmodium falciparum peptides bind specifically to human hepatocytes.

Authors:  Alvaro Puentes; Javier García; Ricardo Vera; Ramsés López; Jorge Suarez; Luis Rodríguez; Hernando Curtidor; Marisol Ocampo; Diana Tovar; Martha Forero; Adriana Bermudez; Jimena Cortes; Mauricio Urquiza; Manuel E Patarroyo
Journal:  Vaccine       Date:  2004-03-12       Impact factor: 3.641

4.  Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells.

Authors:  Javier Eduardo Garcia; Alvaro Puentes; Jorge Súarez; Ramses López; Ricardo Vera; Luis Eduardo Rodríguez; Marisol Ocampo; Hernando Curtidor; Fanny Guzman; Mauricio Urquiza; Manuel Elkin Patarroyo
Journal:  J Hepatol       Date:  2002-02       Impact factor: 25.083

5.  Amplification of a species-specific DNA fragment of Mycobacterium tuberculosis and its possible use in diagnosis.

Authors:  P Del Portillo; L A Murillo; M E Patarroyo
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

6.  Isolation, characterization, and molecular cloning of a specific Mycobacterium tuberculosis antigen gene: identification of a species-specific sequence.

Authors:  C A Parra; L P Londoño; P Del Portillo; M E Patarroyo
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

7.  Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages.

Authors:  L S Schlesinger; S R Hull; T M Kaufman
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

8.  Mycobacterium tuberculosis invades and replicates within type II alveolar cells.

Authors:  L E Bermudez; J Goodman
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

10.  Lipoarabinomannan inhibits nonopsonic binding of Mycobacterium tuberculosis to murine macrophages.

Authors:  R W Stokes; D P Speert
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

View more
  3 in total

1.  Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: potential TB vaccine candidate antigen.

Authors:  Diana P Cifuentes; Marisol Ocampo; Hernando Curtidor; Magnolia Vanegas; Martha Forero; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  BMC Microbiol       Date:  2010-04-13       Impact factor: 3.605

2.  Characterizing the Mycobacterium tuberculosis Rv2707 protein and determining its sequences which specifically bind to two human cell lines.

Authors:  Julie A Chapeton-Montes; David F Plaza; Hernando Curtidor; Martha Forero; Magnolia Vanegas; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  Protein Sci       Date:  2007-12-20       Impact factor: 6.725

3.  Design, Synthesis, and Use of Peptides Derived from Human Papillomavirus L1 Protein for the Modification of Gold Electrode Surfaces by Self-Assembled Monolayers.

Authors:  John Alejandro Lara Carrillo; Ricardo Fierro Medina; Juan Manríquez Rocha; Erika Bustos Bustos; Diego Sebastián Insuasty Cepeda; Javier Eduardo García Castañeda; Zuly Jenny Rivera Monroy
Journal:  Molecules       Date:  2017-11-14       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.